Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Up 839.1% in October

Posted by Jeff Wilder on Nov 13th, 2024

Mangoceuticals, Inc. (NASDAQ:MGRX – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 194,400 shares, a growth of 839.1% from the October 15th total of 20,700 shares. Based on an average daily volume of 353,300 shares, the short-interest ratio is presently 0.6 days. Approximately 15.3% of the company’s stock are short sold.

Mangoceuticals Stock Down 0.4 %

NASDAQ MGRX traded down $0.01 on Wednesday, hitting $2.43. 57,573 shares of the stock were exchanged, compared to its average volume of 236,839. Mangoceuticals has a fifty-two week low of $2.10 and a fifty-two week high of $16.80. The company has a market cap of $4.84 million, a PE ratio of -0.38 and a beta of 2.08. The company has a 50-day moving average price of $33.81 and a 200-day moving average price of $60.71.

Mangoceuticals (NASDAQ:MGRX – Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($20.25) EPS for the quarter. Mangoceuticals had a negative return on equity of 243.34% and a negative net margin of 1,053.93%. The firm had revenue of $0.16 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Mangoceuticals stock. Ackerman Capital Advisors LLC purchased a new position in shares of Mangoceuticals, Inc. (NASDAQ:MGRX – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 873,356 shares of the company’s stock, valued at approximately $206,000. Ackerman Capital Advisors LLC owned approximately 3.52% of Mangoceuticals as of its most recent SEC filing. Institutional investors and hedge funds own 56.72% of the company’s stock.

About Mangoceuticals

(Get Free Report)

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.